Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Hematological Malignancies Disease Industry
Figure Hematological Malignancies Disease Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Hematological Malignancies Disease
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Hematological Malignancies Disease
1.2.2 Downstream
Table Application Segment of Hematological Malignancies Disease
Table Global Hematological Malignancies Disease Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Hematological Malignancies Disease Market by Type
3.1 By Type
3.1.1 Chemotherapy 
Table Major Company List of Chemotherapy 
3.1.2 Immunotherapy 
Table Major Company List of Immunotherapy 
3.1.3 Targeted Therapy 
Table Major Company List of Targeted Therapy 
3.2 Market Size
Table Global Hematological Malignancies Disease Market 2016-2020, by Type, in USD Million
Figure Global Hematological Malignancies Disease Market Growth 2016-2020, by Type, in USD Million
Table Global Hematological Malignancies Disease Market 2016-2020, by Type, in Volume
Figure Global Hematological Malignancies Disease Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Hematological Malignancies Disease Market Forecast 2021-2026, by Type, in USD Million
Table Global Hematological Malignancies Disease Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Affymetrix  (Company Profile, Sales Data etc.)
4.1.1 Affymetrix  Profile
Table Affymetrix  Overview List
4.1.2 Affymetrix  Products & Services
4.1.3 Affymetrix  Business Operation Conditions
Table Business Operation of Affymetrix  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 SkylineDx  (Company Profile, Sales Data etc.)
4.2.1 SkylineDx  Profile
Table SkylineDx  Overview List
4.2.2 SkylineDx  Products & Services
4.2.3 SkylineDx  Business Operation Conditions
Table Business Operation of SkylineDx  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 AgenaBio  (Company Profile, Sales Data etc.)
4.3.1 AgenaBio  Profile
Table AgenaBio  Overview List
4.3.2 AgenaBio  Products & Services
4.3.3 AgenaBio  Business Operation Conditions
Table Business Operation of AgenaBio  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Signal Genetics  (Company Profile, Sales Data etc.)
4.4.1 Signal Genetics  Profile
Table Signal Genetics  Overview List
4.4.2 Signal Genetics  Products & Services
4.4.3 Signal Genetics  Business Operation Conditions
Table Business Operation of Signal Genetics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Cancer Genetics Inc  (Company Profile, Sales Data etc.)
4.5.1 Cancer Genetics Inc  Profile
Table Cancer Genetics Inc  Overview List
4.5.2 Cancer Genetics Inc  Products & Services
4.5.3 Cancer Genetics Inc  Business Operation Conditions
Table Business Operation of Cancer Genetics Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Illumina  (Company Profile, Sales Data etc.)
4.6.1 Illumina  Profile
Table Illumina  Overview List
4.6.2 Illumina  Products & Services
4.6.3 Illumina  Business Operation Conditions
Table Business Operation of Illumina  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 NeoGenomics  (Company Profile, Sales Data etc.)
4.7.1 NeoGenomics  Profile
Table NeoGenomics  Overview List
4.7.2 NeoGenomics  Products & Services
4.7.3 NeoGenomics  Business Operation Conditions
Table Business Operation of NeoGenomics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Exiqon  (Company Profile, Sales Data etc.)
4.8.1 Exiqon  Profile
Table Exiqon  Overview List
4.8.2 Exiqon  Products & Services
4.8.3 Exiqon  Business Operation Conditions
Table Business Operation of Exiqon  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Regulus Therapeutics  (Company Profile, Sales Data etc.)
4.9.1 Regulus Therapeutics  Profile
Table Regulus Therapeutics  Overview List
4.9.2 Regulus Therapeutics  Products & Services
4.9.3 Regulus Therapeutics  Business Operation Conditions
Table Business Operation of Regulus Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Rosetta Genomics  (Company Profile, Sales Data etc.)
4.10.1 Rosetta Genomics  Profile
Table Rosetta Genomics  Overview List
4.10.2 Rosetta Genomics  Products & Services
4.10.3 Rosetta Genomics  Business Operation Conditions
Table Business Operation of Rosetta Genomics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Sequenta  (Company Profile, Sales Data etc.)
4.11.1 Sequenta  Profile
Table Sequenta  Overview List
4.11.2 Sequenta  Products & Services
4.11.3 Sequenta  Business Operation Conditions
Table Business Operation of Sequenta  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Takeda Pharma  (Company Profile, Sales Data etc.)
4.12.1 Takeda Pharma  Profile
Table Takeda Pharma  Overview List
4.12.2 Takeda Pharma  Products & Services
4.12.3 Takeda Pharma  Business Operation Conditions
Table Business Operation of Takeda Pharma  (Sales Revenue, Cost, Gross Margin)
4.13 Celgene  (Company Profile, Sales Data etc.)
4.13.1 Celgene  Profile
Table Celgene  Overview List
4.13.2 Celgene  Products & Services
4.13.3 Celgene  Business Operation Conditions
Table Business Operation of Celgene  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Amgen  (Company Profile, Sales Data etc.)
4.14.1 Amgen  Profile
Table Amgen  Overview List
4.14.2 Amgen  Products & Services
4.14.3 Amgen  Business Operation Conditions
Table Business Operation of Amgen  (Sales Revenue, Cost, Gross Margin)
4.15 Ono Pharma  (Company Profile, Sales Data etc.)
4.15.1 Ono Pharma  Profile
Table Ono Pharma  Overview List
4.15.2 Ono Pharma  Products & Services
4.15.3 Ono Pharma  Business Operation Conditions
Table Business Operation of Ono Pharma  (Sales Revenue, Cost, Gross Margin)
4.16 Abbott  (Company Profile, Sales Data etc.)
4.16.1 Abbott  Profile
Table Abbott  Overview List
4.16.2 Abbott  Products & Services
4.16.3 Abbott  Business Operation Conditions
Table Business Operation of Abbott  (Sales Revenue, Cost, Gross Margin)
4.17 BMS  (Company Profile, Sales Data etc.)
4.17.1 BMS  Profile
Table BMS  Overview List
4.17.2 BMS  Products & Services
4.17.3 BMS  Business Operation Conditions
Table Business Operation of BMS  (Sales Revenue, Cost, Gross Margin)
4.18 Mundipharma  (Company Profile, Sales Data etc.)
4.18.1 Mundipharma  Profile
Table Mundipharma  Overview List
4.18.2 Mundipharma  Products & Services
4.18.3 Mundipharma  Business Operation Conditions
Table Business Operation of Mundipharma  (Sales Revenue, Cost, Gross Margin)
4.19 Novartis  (Company Profile, Sales Data etc.)
4.19.1 Novartis  Profile
Table Novartis  Overview List
4.19.2 Novartis  Products & Services
4.19.3 Novartis  Business Operation Conditions
Table Business Operation of Novartis  (Sales Revenue, Cost, Gross Margin)
4.20 MorphoSys (Company Profile, Sales Data etc.)
4.20.1 MorphoSys Profile
Table MorphoSys Overview List
4.20.2 MorphoSys Products & Services
4.20.3 MorphoSys Business Operation Conditions
Table Business Operation of MorphoSys (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Hematological Malignancies Disease Sales Revenue 2016-2020, by Company, in USD Million
Table Global Hematological Malignancies Disease Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Hematological Malignancies Disease Sales Revenue Share in 2020, by Company, in USD Million
Table Global Hematological Malignancies Disease Sales Volume 2016-2020, by Company, in Volume
Table Global Hematological Malignancies Disease Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Hematological Malignancies Disease Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Hematological Malignancies Disease Market Concentration, in 2020
Figure Europe Hematological Malignancies Disease Market Market Concentration, in 2020
Figure Asia-Pacific Hematological Malignancies Disease MMarket Concentration, in 2020
Figure South America Hematological Malignancies Disease Market Concentration, in 2020
Figure Middle East & Africa Hematological Malignancies Disease Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Leukemia 
Figure Hematological Malignancies Disease Demand in Leukemia , 2016-2020, in USD Million
Figure Hematological Malignancies Disease Demand in Leukemia , 2016-2020, in Volume
6.1.2 Demand in Lymphoma 
Figure Hematological Malignancies Disease Demand in Lymphoma , 2016-2020, in USD Million
Figure Hematological Malignancies Disease Demand in Lymphoma , 2016-2020, in Volume
6.1.3 Demand in Myeloma
Figure Hematological Malignancies Disease Demand in Myeloma, 2016-2020, in USD Million
Figure Hematological Malignancies Disease Demand in Myeloma, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Hematological Malignancies Disease Demand Forecast 2021-2026, by Application, in USD Million
Figure Hematological Malignancies Disease Market Growth 2021-2026, by Application, in USD Million
Figure Hematological Malignancies Disease Market Share in 2026, by Application, in USD Million
Table Hematological Malignancies Disease Demand Forecast 2021-2026, by Application, in Volume
Table Hematological Malignancies Disease Market Growth 2021-2026, by Application, in Volume
Table Hematological Malignancies Disease Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Hematological Malignancies Disease Production 2016-2020, by Region, in USD Million
Table Hematological Malignancies Disease Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Hematological Malignancies Disease Market 2016-2020, by Region, in USD Million
Table Global Hematological Malignancies Disease Market Share 2016-2020, by Region, in USD Million
Table Global Hematological Malignancies Disease Market 2016-2020, by Region, in Volume
Table Global Hematological Malignancies Disease Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Hematological Malignancies Disease Market Size and Growth 2016-2020, in USD Million
Figure North America Hematological Malignancies Disease Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
Table North America Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Hematological Malignancies Disease Market Size and Growth 2016-2020, in USD Million
Figure Europe Hematological Malignancies Disease Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
Table Europe Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Hematological Malignancies Disease Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Hematological Malignancies Disease Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Hematological Malignancies Disease Market Size and Growth 2016-2020, in USD Million
Figure South America Hematological Malignancies Disease Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
Table South America Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Hematological Malignancies Disease Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Hematological Malignancies Disease Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Hematological Malignancies Disease Market Forecast 2021-2026, by Region, in USD Million
Table Hematological Malignancies Disease Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Hematological Malignancies Disease
2. Table Application Segment of Hematological Malignancies Disease
3. Table Global Hematological Malignancies Disease Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Immunotherapy 
5. Table Major Company List of Targeted Therapy 
6. Table Global Hematological Malignancies Disease Market 2016-2020, by Type, in USD Million
7. Table Global Hematological Malignancies Disease Market 2016-2020, by Type, in Volume
8. Table Global Hematological Malignancies Disease Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Hematological Malignancies Disease Market Forecast 2021-2026, by Type, in Volume
10. Table Affymetrix  Overview List
11. Table Business Operation of Affymetrix  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table SkylineDx  Overview List
13. Table Business Operation of SkylineDx  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table AgenaBio  Overview List
15. Table Business Operation of AgenaBio  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Signal Genetics  Overview List
17. Table Business Operation of Signal Genetics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Cancer Genetics Inc  Overview List
19. Table Business Operation of Cancer Genetics Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Illumina  Overview List
21. Table Business Operation of Illumina  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table NeoGenomics  Overview List
23. Table Business Operation of NeoGenomics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Exiqon  Overview List
25. Table Business Operation of Exiqon  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Regulus Therapeutics  Overview List
27. Table Business Operation of Regulus Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Rosetta Genomics  Overview List
29. Table Business Operation of Rosetta Genomics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Sequenta  Overview List
31. Table Business Operation of Sequenta  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Takeda Pharma  Overview List
33. Table Business Operation of Takeda Pharma  (Sales Revenue, Cost, Gross Margin)
34. Table Celgene  Overview List
35. Table Business Operation of Celgene  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
36. Table Amgen  Overview List
37. Table Business Operation of Amgen  (Sales Revenue, Cost, Gross Margin)
38. Table Ono Pharma  Overview List
39. Table Business Operation of Ono Pharma  (Sales Revenue, Cost, Gross Margin)
40. Table Abbott  Overview List
41. Table Business Operation of Abbott  (Sales Revenue, Cost, Gross Margin)
42. Table BMS  Overview List
43. Table Business Operation of BMS  (Sales Revenue, Cost, Gross Margin)
44. Table Mundipharma  Overview List
45. Table Business Operation of Mundipharma  (Sales Revenue, Cost, Gross Margin)
46. Table Novartis  Overview List
47. Table Business Operation of Novartis  (Sales Revenue, Cost, Gross Margin)
48. Table MorphoSys Overview List
49. Table Business Operation of MorphoSys (Sales Revenue, Cost, Gross Margin)
50. Table Global Hematological Malignancies Disease Sales Revenue 2016-2020, by Company, in USD Million
51. Table Global Hematological Malignancies Disease Sales Revenue Share 2016-2020, by Company, in USD Million
52. Table Global Hematological Malignancies Disease Sales Volume 2016-2020, by Company, in Volume
53. Table Global Hematological Malignancies Disease Sales Volume Share 2016-2020, by Company, in Volume
54. Table Regional Demand Comparison List
55. Table Major Application in Different Regions
56. Table Hematological Malignancies Disease Demand Forecast 2021-2026, by Application, in USD Million
57. Table Hematological Malignancies Disease Demand Forecast 2021-2026, by Application, in Volume
58. Table Hematological Malignancies Disease Market Growth 2021-2026, by Application, in Volume
59. Table Hematological Malignancies Disease Market Share in 2026, by Application, in Volume
60. Table Hematological Malignancies Disease Production 2016-2020, by Region, in USD Million
61. Table Hematological Malignancies Disease Production 2016-2020, by Region, in Volume
62. Table Global Hematological Malignancies Disease Market 2016-2020, by Region, in USD Million
63. Table Global Hematological Malignancies Disease Market Share 2016-2020, by Region, in USD Million
64. Table Global Hematological Malignancies Disease Market 2016-2020, by Region, in Volume
65. Table Global Hematological Malignancies Disease Market Share 2016-2020, by Region, in Volume
66. Table North America Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
67. Table North America Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
68. Table Europe Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
69. Table Europe Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
70. Table Asia-Pacific Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
71. Table Asia-Pacific Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
72. Table South America Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
73. Table South America Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
74. Table Middle East & Africa Hematological Malignancies Disease Market Size 2016-2020, by Country, in USD Million
75. Table Middle East & Africa Hematological Malignancies Disease Market Size 2016-2020, by Country, in Volume
76. Table Hematological Malignancies Disease Market Forecast 2021-2026, by Region, in USD Million
77. Table Hematological Malignancies Disease Market Forecast 2021-2026, by Region, in Volume
78. Table Price Factors List